Selective nicotinic receptor consequences in APPSWE transgenic mice

被引:57
作者
Bednar, I
Paterson, D
Marutle, A
Pham, TM
Svedberg, M
Hellström-Lindahl, E
Mousavi, M
Court, J
Morris, C
Perry, E
Mohammed, A
Zhang, X
Nordberg, A
机构
[1] Huddinge Univ Hosp, Div Mol Neuropharmacol, S-14186 Huddinge, Sweden
[2] Huddinge Univ Hosp, Karolinska Inst, Dept Clin Neurosci Occupat Therapy & Elderly Care, Div Geriatr Med, S-14186 Huddinge, Sweden
[3] Joint MRC Newcastle Univ, Newcastle Gen Hosp, Ctr Dev Clin Brain Aging, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
关键词
D O I
10.1006/mcne.2002.1112
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The nicotinic (nAChRs) and muscarinic (mAChRs) acetylcholine receptors and acetylcholinesterase (AChE) activity were studied in the brains of APP(SWE) transgenic mice (Tg+) and age-matched nontransgenic controls (Tg-) that were between 4 and 19 months of age. A significant increase in the binding of I-125-labeled alpha-bungarotoxin (alpha7 nAChRs) was observed in most brain regions analyzed in 4-month-old Tg+ mice, preceding learning and memory impairments and amylold-beta (Abeta) pathology. The enhanced alpha7 receptor binding was still detectable at 17-19 months of age. Increase in [H-3]cytisine binding (alpha4beta2 nAChRs) was measured at 17-19 months of age in Tg + mice, at the same age when the animals showed heavy Abeta pathology. No significant changes in [H-3]pirenzepine (M1 mAChRs) or [H-3]AFDX 384 (M2 mAChRs) binding sites were found at any age studied. The upregulation of the nAChRs probably reflects compensatory mechanisms in response to Abeta burden in the brains of Tg+ mice.
引用
收藏
页码:354 / 365
页数:12
相关论文
共 56 条
  • [11] Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease
    Guan, ZZ
    Zhang, X
    Ravid, R
    Nordberg, A
    [J]. JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) : 237 - 243
  • [12] Regional distribution of nicotinic receptor subunit mRNAs in human brain:: comparison between Alzheimer and normal brain
    Hellström-Lindahl, E
    Mousavi, M
    Zhang, X
    Ravid, R
    Nordberg, A
    [J]. MOLECULAR BRAIN RESEARCH, 1999, 66 (1-2): : 94 - 103
  • [13] Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging
    Hellström-Lindahl, E
    Court, JA
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2000, 113 (1-2) : 159 - 168
  • [14] Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes
    Hernandez, D
    Sugaya, K
    Qu, TY
    McGowan, E
    Duff, K
    McKinney, M
    [J]. NEUROREPORT, 2001, 12 (07) : 1377 - 1384
  • [15] Nontoxic amyloid beta peptide (1-42) suppresses acetylcholine synthesis - Possible role in cholinergic dysfunction in Alzheimer's disease
    Hoshi, M
    Takashima, A
    Murayama, M
    Yasutake, K
    Yoshida, N
    Ishiguro, K
    Hoshino, T
    Imahori, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (04) : 2038 - 2041
  • [16] Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
    Hsia, AY
    Masliah, E
    McConlogue, L
    Yu, GQ
    Tatsuno, G
    Hu, K
    Kholodenko, D
    Malenka, RC
    Nicoll, RA
    Mucke, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) : 3228 - 3233
  • [17] Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice
    Hsiao, K
    Chapman, P
    Nilsen, S
    Eckman, C
    Harigaya, Y
    Younkin, S
    Yang, FS
    Cole, G
    [J]. SCIENCE, 1996, 274 (5284) : 99 - 102
  • [18] AGE-RELATED CNS DISORDER AND EARLY DEATH IN TRANSGENIC FVB/N MICE OVEREXPRESSING ALZHEIMER AMYLOID PRECURSOR PROTEINS
    HSIAO, KK
    BORCHELT, DR
    OLSON, K
    JOHANNSDOTTIR, R
    KITT, C
    YUNIS, W
    XU, S
    ECKMAN, C
    YOUNKIN, S
    PRICE, D
    IADECOLA, C
    CLARK, HB
    CARLSON, G
    [J]. NEURON, 1995, 15 (05) : 1203 - 1218
  • [19] APP(Sw) transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1
    Irizarry, MC
    McNamara, M
    Fedorchak, K
    Hsiao, K
    Hyman, BT
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (09) : 965 - 973
  • [20] Abundance of the longer A beta(42) in neocortical and cerebrovascular amyloid beta deposits in Swedish familial Alzheimer's disease and Down's syndrome
    Kalaria, RN
    Cohen, DL
    Greenberg, BD
    Savage, MJ
    Bogdanovic, NE
    Winblad, B
    Lannfelt, L
    Adem, A
    [J]. NEUROREPORT, 1996, 7 (08) : 1377 - 1381